Andrew Galler
Stock Analyst at Morgan Stanley
(0.57)
# 4,115
Out of 5,084 analysts
30
Total ratings
33.33%
Success rate
-15.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Maintains: Equal-Weight | $34 → $36 | $40.24 | -10.54% | 14 | Nov 10, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $9.93 | +51.10% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $6.96 | +158.81% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $64.67 | -42.79% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $81.64 | -31.41% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $6.87 | +162.20% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $77.83 | -30.61% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $63.10 | -20.75% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $3.54 | +1,142.94% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $25.49 | +1,092.86% | 1 | Nov 9, 2021 |
Immunocore Holdings
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $34 → $36
Current: $40.24
Upside: -10.54%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $9.93
Upside: +51.10%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $6.96
Upside: +158.81%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $64.67
Upside: -42.79%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $81.64
Upside: -31.41%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $6.87
Upside: +162.20%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $77.83
Upside: -30.61%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $63.10
Upside: -20.75%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $3.54
Upside: +1,142.94%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $25.49
Upside: +1,092.86%